468 related articles for article (PubMed ID: 17916030)
21. Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder.
Abbo AH; Jones DR; Masters AR; Stewart JC; Fourez L; Knapp DW
J Vet Intern Med; 2010; 24(5):1124-30. PubMed ID: 20695986
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder.
Boria PA; Glickman NW; Schmidt BR; Widmer WR; Mutsaers AJ; Adams LG; Snyder PW; DiBernardi L; de Gortari AE; Bonney PL; Knapp DW
Vet Comp Oncol; 2005 Jun; 3(2):73-80. PubMed ID: 19379215
[TBL] [Abstract][Full Text] [Related]
23. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder.
Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM
J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy.
Mutsaers AJ; Mohammed SI; DeNicola DB; Snyder PW; Glickman NW; Bennett PF; de Gortari AE; Bonney PL; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):181-6. PubMed ID: 15664302
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs.
Moore AS; Cardona A; Shapiro W; Madewell BR
J Vet Intern Med; 1990; 4(3):148-52. PubMed ID: 2366224
[TBL] [Abstract][Full Text] [Related]
26. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
[TBL] [Abstract][Full Text] [Related]
27. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
[TBL] [Abstract][Full Text] [Related]
28. Piroxicam for bladder cancer.
Barsanti JA
J Vet Intern Med; 1995; 9(2):113-4. PubMed ID: 7760310
[No Abstract] [Full Text] [Related]
29. Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985-2010).
Higuchi T; Burcham GN; Childress MO; Rohleder JJ; Bonney PL; Ramos-Vara JA; Knapp DW
J Am Vet Med Assoc; 2013 Feb; 242(4):499-506. PubMed ID: 23363282
[TBL] [Abstract][Full Text] [Related]
30. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
[TBL] [Abstract][Full Text] [Related]
31. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
[TBL] [Abstract][Full Text] [Related]
32. Palliative ultrasound-guided endoscopic diode laser ablation of transitional cell carcinomas of the lower urinary tract in dogs.
Cerf DJ; Lindquist EC
J Am Vet Med Assoc; 2012 Jan; 240(1):51-60. PubMed ID: 22171755
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of nephrotoxicosis associated with a four-hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms.
Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty M; Powers BE; Henkel SE; Withrow SJ
J Am Vet Med Assoc; 1993 Jun; 202(11):1845-8. PubMed ID: 8320153
[TBL] [Abstract][Full Text] [Related]
34. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.
Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM
J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737
[TBL] [Abstract][Full Text] [Related]
35. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
[TBL] [Abstract][Full Text] [Related]
36. Ureterocolonic anastomosis in a dog with transitional cell carcinoma of the urinary bladder.
Montgomery RD; Hankes GH
J Am Vet Med Assoc; 1987 Jun; 190(11):1427-9. PubMed ID: 3610753
[TBL] [Abstract][Full Text] [Related]
37. Results of biopsy via transurethral cystoscopy and cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008).
Childress MO; Adams LG; Ramos-Vara JA; Freeman LJ; He S; Constable PD; Knapp DW
J Am Vet Med Assoc; 2011 Aug; 239(3):350-6. PubMed ID: 21801049
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous metastasis of transitional cell carcinoma in 12 dogs.
Reed LT; Knapp DW; Miller MA
Vet Pathol; 2013 Jul; 50(4):676-81. PubMed ID: 23136183
[TBL] [Abstract][Full Text] [Related]
39. [Transitional cell carcinoma of the urinary bladder of a dog].
Odendaal JS; Bastianello SS
J S Afr Vet Assoc; 1982 Dec; 53(4):258-60. PubMed ID: 7182501
[TBL] [Abstract][Full Text] [Related]
40. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
